|Tested species reactivity||Human, Rat|
|Published species reactivity||Human|
|Host / Isotype||Mouse / IgG1|
|Immunogen||Human breast cancer MCF-7 Cells.|
|Contains||0.08% sodium azide|
|Storage Conditions||-20° C, Avoid Freeze/Thaw Cycles|
|Tested Applications||Dilution *|
|Flow Cytometry (Flow)||Assay Dependent|
|Gel Shift (GS)||Assay Dependent|
|Immunohistochemistry (Frozen) (IHC (F))||Assay Dependent|
|Immunohistochemistry (Paraffin) (IHC (P))||Assay Dependent|
|Immunoprecipitation (IP)||Assay Dependent|
|Western Blot (WB)||Assay Dependent|
* Suggested working dilutions are given as a guide only. It is recommended that the user titrate the product for use in their own experiment using appropriate negative and positive controls.
A suggested positive control for this product is SKBR-3, HeLa or MCF-7 cells.
LRP is a protein overexpressed in many neoplastic tissues and cell lines. Expression of LRP predicts a poor response to chemotherapy.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
MVP expression in the prediction of clinical outcome of locally advanced oral squamous cell carcinoma patients treated with radiotherapy.
MA1-12619 was used in immunohistochemistry to study the role and prognostic value of Major Vault Protein in locally advanced oral squamous cell carcinoma
|Henríquez-Hernández LA,Moreno M,Rey A,Lloret M,Lara PC||Radiation oncology (London, England) (7:null)||2012|
Involvement of extracellular signal-regulated kinase/mitogen-activated protein kinase pathway in multidrug resistance induced by HBx in hepatoma cell line.
MA1-12619 was used in western blot to investigate the role of HBx protein on the occurrence of multidrug resistance in hepatoma cell line
|Guan J,Chen XP,Zhu H,Luo SF,Cao B,Ding L||World journal of gastroenterology (10:3522)||2004|